Pharmacogenetics of antipsychotic-induced metabolic disturbances: state-of-the-art

Pharmacogenetics of antipsychotic-induced metabolic disturbances: state-of-the-art

Antipsychotics are the main pharmaceutical agents in treatment of schizophrenia and other mental disorders. According to literature data up to 60% of patients with schizophrenia have antipsychotic-induced metabolic disturbances. The main objective of pharmacogenetic studies is search for predictors...

Full description

Saved in:
Bibliographic Details
Main Authors: R. F. Nasyrova, N. A. Sivakova, D. V. Ivashchenko, D. N. Sosin, E. E. Ershov, K. A. Sosina, L. Sh. Akhmetova, O. V. Volikova, T. Z. Beybalayeva, N. G. Neznanov
Format: Article
Language:Russian
Published: Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation 2018-07-01
Series:Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Subjects:
антипсихотики
персонализированная медицина
шизофрения
метаболические нарушения
фармакогенетика
antipsychotics
personalized medicine
schizophrenia
metabolic disturbances
pharmacogenetics
Online Access:https://www.bekhterevreview.com/jour/article/view/33
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items